about
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboratio...
Read More
5.37
-0.02
(-0.37%)
121.5K
XNAS Volume
XNAS 08 Sep, 2025 10:27 AM (EDT)
Not Eligible
Affordable Valuation
Technically Neutral
CureVac NV Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..